Clinical Trials Browser

Esophageal Neoplasms × epigallocatechin gallate × Gastrointestinal × Clear all

NCT06398405 2024-05-03

A Phase II Clinical Study of Epigallocatechin-3-gallate in Patients With Esophageal Squamous Cancer

Phase 2 Recruiting

Gastrointestinal

Deglutition Disorders, Esophageal Neoplasms